Mumbai Angels Reinvests in Biotech Startup Mestastop Solutions’ Pursuit of Anti-Metastatic Breakthrough
- ByStartupStory | March 5, 2024
Mumbai Angels, a leading private investment platform, has once again thrown its support behind Bengaluru-based biotech firm Mestastop Solutions. This latest round of funding, which saw participation from 92 angel investors and Malpani Ventures, marks Mumbai Angels’ second investment in Mestastop since its initial backing in 2020.
Mestastop Solutions, a pioneering deep-tech startup, specializes in cancer metastasis drug discovery and predictive diagnostics. The company is set to utilize the newly acquired funds to develop a Proof of Concept (PoC) centered around a novel target. Additionally, Mestastop aims to position two approved drugs for clinical trials, focusing on delaying metastasis for patients with primary tumors in an adjuvant setting.
Nandini Mansinghka, Co-Founder and CEO of Mumbai Angels, emphasized the organization’s commitment to Mestastop’s noble cause, stating, “Mestastop is working on a noble cause to develop anti-metastatic drugs. Our continued investment in the company indicates our confidence and belief in Mestastop Solutions’ potential to make a meaningful impact.”
Arnab Roy Chowdhury, Founder of Mestastop Solutions, expressed his gratitude for the support, saying, “With this investment, we intend to realize our dream of offering unique, tech-backed strategies to develop anti-metastatic drugs that focus on delaying metastasis causing the spread of cancer.”
Mestastop’s innovative approach involves leveraging the functional properties of patient primary tumor samples to identify distinct phenotypes acting as markers of metastatic cells. Over the past five years, the company has seamlessly integrated wet lab biology and machine learning algorithms, resulting in three proprietary platforms to unravel metastasis biology.
Chowdhury highlighted the company’s global reach, noting, “The company has filed for multiple patents in the USA and Europe and currently has two ongoing European collaborations and three Indian collaborations.”
Follow Startup Story
Related Posts
